About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(GFAP-cre/ERT2)505Fmv
transgene insertion 505, Flora M Vaccarino
MGI:3774167
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Aspanur7/Aspanur7
Slc13a3tm1c(KOMP)Wtsi/Slc13a3tm1c(KOMP)Wtsi
Tg(GFAP-cre/ERT2)505Fmv/0
mixed MGI:7660713


Genotype
MGI:7660713
cn1
Allelic
Composition
Aspanur7/Aspanur7
Slc13a3tm1c(KOMP)Wtsi/Slc13a3tm1c(KOMP)Wtsi
Tg(GFAP-cre/ERT2)505Fmv/0
Genetic
Background
mixed
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aspanur7 mutation (1 available); any Aspa mutation (26 available)
Slc13a3tm1c(KOMP)Wtsi mutation (0 available); any Slc13a3 mutation (34 available)
Tg(GFAP-cre/ERT2)505Fmv mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• at 16 weeks of age, concentration of the aspartoacylase substrate N-acetyl-L-aspartate (NAA) in brain in tamoxifen-treated mice is 55% below that in tamoxifen-treated control homozygous Aspanur7 mice, indicating partial reversal of increased brain NAA levels seen in Canavan disease model Aspanur7 mice
• the extent of cerebellar vacuolation in tamoxifen-treated mice is not different from that seen in homozygous Aspanur7 mice

behavior/neurological
• accelerating rotarod retention time is increased by 1 week after completion of tamoxifen administration and remains elevated through 7 additional weeks compared to homozygous Aspanur7 mice, indicating improved motor function





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory